Proteomic and metabolomic analysis of cardioprotection: Interplay between protein kinase C epsilon and delta in regulating glucose metabolism of murine hearts

Journal of Molecular and Cellular Cardiology

Volumn 46, Issue 2, 2009, Pages 268-277

  Mayr, Manuel ^a   Liem, David ^d   Zhang, Jun ^d   Li, Xiaohai ^d   Avliyakulov, Nuraly K ^d   Yang, Jeong In ^d   Young, Glen ^d   Vondriska, Tom M ^d   Ladroue, Christophe ^c   Madhu, Basetti ^b   Griffiths, John R ^b   Gomes, Aldrin ^d   Xu, Qingbo ^a   Ping, Peipei ^d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardioprotection; Metabolism; Mitochondria; Preconditioning; Protein kinase C; Proteomics

Indexed keywords

ADENOSINE; ASPARTATE AMINOTRANSFERASE; CHOLINE; CREATINE; CREATINE KINASE; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; LACTATE DEHYDROGENASE; LACTIC ACID; MALATE DEHYDROGENASE; MITOCHONDRIAL PROTEIN; NUCLEOTIDE; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PYRUVATE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOSOL; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GEL ELECTROPHORESIS; GLUCOSE METABOLISM; GLYCOLYSIS; HEART; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART PROTECTION; MALE; METABOLOMICS; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; PROTON NUCLEAR MAGNETIC RESONANCE; REPERFUSION INJURY;

ANIMALS; DISEASE MODELS, ANIMAL; GLUCOSE; METABOLOMICS; MICE; MITOCHONDRIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PROTEIN BINDING; PROTEIN KINASE C-DELTA; PROTEIN KINASE C-EPSILON; PROTEOMICS;

MURINAE; MUS;

EID: 58149279280     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.10.008     Document Type: Article

References (44)

1. Mackay K., and Mochly-Rosen D. Localization, anchoring, and functions of protein kinase C isozymes in the heart. J. Mol. Cell. Cardiol. 33 7 (2001) 1301-1307
2. Hahn H.S., Yussman M.G., Toyokawa T., Marreez Y., Barrett T.J., Hilty K.C., et al. Ischemic protection and myofibrillar cardiomyopathy: dose-dependent effects of in vivo deltaPKC inhibition. Circ. Res. 91 8 (2002) 741-748
3. Chen L., Hahn H., Wu G., Chen C.H., Liron T., Schechtman D., et al. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc. Natl. Acad. Sci. U. S. A. 98 20 (2001) 11114-11119
4. Inagaki K., Hahn H.S., Dorn II G.W., and Mochly-Rosen D. Additive protection of the ischemic heart ex vivo by combined treatment with {delta}-protein kinase C inhibitor and {epsilon}-protein kinase C activator. Circulation (2003)
5. Murriel C.L., Churchill E., Inagaki K., Szweda L.I., and Mochly-Rosen D. Protein kinase C{delta} activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria. J. Biol. Chem. 279 46 (2004) 47985-47991
6. Dorn II G.W., Souroujon M.C., Liron T., Chen C.H., Gray M.O., Zhou H.Z., et al. Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation. Proc. Natl. Acad. Sci. U. S. A. 96 22 (1999) 12798-12803
7. Liu G.S., Cohen M.V., Mochly-Rosen D., and Downey J.M. Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes. J. Mol. Cell. Cardiol. 31 10 (1999) 1937-1948
8. Zhao J., Renner O., Wightman L., Sugden P.H., Stewart L., Miller A.D., et al. The expression of constitutively active isotypes of protein kinase C to investigate preconditioning. J. Biol. Chem. 273 36 (1998) 23072-23079
9. Bolli R. The late phase of preconditioning. Circ. Res. 87 11 (2000) 972-983
10. Kloner R.A., and Jennings R.B. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation 104 24 (2001) 2981-2989
11. Kloner R.A., and Jennings R.B. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2. Circulation 104 25 (2001) 3158-3167
12. Ping P., Song C., Zhang J., Guo Y., Cao X., Li R.C., et al. Formation of protein kinase C(epsilon)-Lck signaling modules confers cardioprotection. J. Clin. Invest. 109 4 (2002) 499-507
13. Ping P., Zhang J., Pierce Jr. W.M., and Bolli R. Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotection. Circ. Res. 88 1 (2001) 59-62
14. Baines C.P., Zhang J., Wang G.W., Zheng Y.T., Xiu J.X., Cardwell E.M., et al. Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. Circ. Res. 90 4 (2002) 390-397
15. Zhang J., Baines C.P., Zong C., Cardwell E.M., Wang G., Vondriska T.M., et al. Functional proteomic analysis of a three-tier PKCepsilon-Akt-eNOS signaling module in cardiac protection. Am. J. Physiol. Heart. Circ. Physiol. 288 2 (2005) H954-H961
16. Mayr M., Metzler B., Chung Y.L., McGregor E., Mayr U., Troy H., et al. Ischemic preconditioning exaggerates cardiac damage in PKC-{delta} null mice. Am. J. Physiol. Heart Circ. Physiol. 287 2 (2004) H946-H956
17. Mayr M., Chung Y.L., Mayr U., McGregor E., Troy H., Baier G., et al. Loss of PKC-{delta} alters cardiac metabolism. Am. J. Physiol. Heart Circ. Physiol. 287 2 (2004) H937-H945
18. Pass J.M., Zheng Y., Wead W.B., Zhang J., Li R.C., Bolli R., et al. PKCepsilon activation induces dichotomous cardiac phenotypes and modulates PKCepsilon-RACK interactions and RACK expression. Am. J. Physiol. Heart Circ. Physiol. 280 3 (2001) H946-H955
19. Leitges M., Mayr M., Braun U., Mayr U., Li C., Pfister G., et al. Exacerbated vein graft arteriosclerosis in protein kinase Cdelta-null mice. J. Clin. Invest. 108 10 (2001) 1505-1512
20. Mayr M., Zampetaki A., Sidibe A., Mayr U., Yin X., De Souza A.I., et al. Proteomic and metabolomic analysis of smooth muscle cells derived from the arterial media and adventitial progenitors of apolipoprotein E-deficient mice. Circ. Res. 102 9 (2008) 1046-1056
21. Gomes A.V., Zong C., Edmondson R.D., Li X., Stefani E., Zhang J., et al. Mapping the murine cardiac 26S proteasome complexes. Circ. Res. 99 4 (2006) 362-371
22. Wang G., Liem D.A., Vondriska T.M., Honda H.M., Korge P., Pantaleon D.M., et al. Nitric oxide donors protect murine myocardium against infarction via modulation of mitochondrial permeability transition. Am. J. Physiol. Heart Circ. Physiol. 288 3 (2005) H1290-H1295
23. Mayr M., Yusuf S., Weir G., Chung Y.L., Mayr U., Yin X., et al. Combined metabolomic and proteomic analysis of human atrial fibrillation. J. Am. Coll. Cardiol. 51 5 (2008) 585-594
24. Baines C.P., Song C.X., Zheng Y.T., Wang G.W., Zhang J., Wang O.L., et al. Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ. Res. 92 8 (2003) 873-880
25. Rybin V.O., Guo J., Gertsberg Z., Elouardighi H., and Steinberg S.F. Protein kinase Cepsilon (PKCepsilon) and Src control PKCdelta activation loop phosphorylation in cardiomyocytes. J. Biol. Chem. 282 32 (2007) 23631-23638
26. Liu Y., Belkina N.V., Graham C., and Shaw S. Independence of protein kinase C-delta activity from activation loop phosphorylation: structural basis and altered functions in cells. J. Biol. Chem. 281 17 (2006) 12102-12111
27. Churchill E.N., Murriel C.L., Chen C.H., Mochly-Rosen D., and Szweda L.I. Reperfusion-induced translocation of deltaPKC to cardiac mitochondria prevents pyruvate dehydrogenase reactivation. Circ. Res. 97 1 (2005) 78-85
28. Ping P., Zhang J., Qiu Y., Tang X.L., Manchikalapudi S., Cao X., et al. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ. Res. 81 3 (1997) 404-414
29. Mayr M., Madhu B., and Xu Q. Proteomics and metabolomics combined in cardiovascular research. Trends Cardiovasc. Med. 17 2 (2007) 43-48
30. Depre C., Vanoverschelde J.L., and Taegtmeyer H. Glucose for the heart. Circulation 99 4 (1999) 578-588
31. Vogt A.M., Poolman M., Ackermann C., Yildiz M., Schoels W., Fell D.A., et al. Regulation of glycolytic flux in ischemic preconditioning. A study employing metabolic control analysis. J. Biol. Chem. 277 27 (2002) 24411-24419
32. Edmondson R.D., Vondriska T.M., Biederman K.J., Zhang J., Jones R.C., Zheng Y., et al. Protein kinase C epsilon signaling complexes include metabolism- and transcription/translation-related proteins: complimentary separation techniques with LC/MS/MS. Mol. Cell. Proteomics 1 6 (2002) 421-433
33. Cross H.R., Murphy E., Bolli R., Ping P., and Steenbergen C. Expression of activated PKC epsilon (PKC epsilon) protects the ischemic heart, without attenuating ischemic H(+) production. J. Mol. Cell. Cardiol. 34 3 (2002) 361-367
34. McCarthy J., McLeod C.J., Minners J., Essop M.F., Ping P., and Sack M.N. PKCepsilon activation augments cardiac mitochondrial respiratory post-anoxic reserve-a putative mechanism in PKCepsilon cardioprotection. J. Mol. Cell. Cardiol. 38 4 (2005) 697-700
35. Gray M.O., Zhou H.Z., Schafhalter-Zoppoth I., Zhu P., Mochly-Rosen D., and Messing R.O. Preservation of base-line hemodynamic function and loss of inducible cardioprotection in adult mice lacking protein kinase C epsilon. J. Biol. Chem. 279 5 (2004) 3596-3604
36. Klein G., Schaefer A., Hilfiker-Kleiner D., Oppermann D., Shukla P., Quint A., et al. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon. Circ. Res. 96 7 (2005) 748-755
37. Mayr M., Siow R., Chung Y.L., Mayr U., Griffiths J.R., and Xu Q. Proteomic and metabolomic analysis of vascular smooth muscle cells: role of PKCdelta. Circ. Res. 94 10 (2004) e87-e96
38. Fryer R.M., Wang Y., Hsu A.K., and Gross G.J. Essential activation of PKC-delta in opioid-initiated cardioprotection. Am. J. Physiol. Heart Circ. Physiol 280 3 (2001) H1346-H1353
39. Fryer R.M., Hsu A.K., Wang Y., Henry M., Eells J., and Gross G.J. PKC-delta inhibition does not block preconditioning-induced preservation in mitochondrial ATP synthesis and infarct size reduction in rats. Basic Res. Cardiol. 97 1 (2002) 47-54
40. Bates E., Bode C., Costa M., Gibson C.M., Granger C., Green C., et al. Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Circulation 117 7 (2008) 886-896
41. Metzler B., Xu Q., and Mayr M. Letter by Metzler et al regarding article, "Intracoronary KAI-9803 as an adjunct to primary coronary intervention for acute ST-segment elevation myocardial infarction". Circulation 118 4 (2008) e80
42. Mayr M., Chung Y.L., Mayr U., Yin X., Ly L., Troy H., et al. Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism. Arterioscler. Thromb. Vasc. Biol. 25 10 (2005) 2135-2142
43. Sun J., Morgan M., Shen R.F., Steenbergen C., and Murphy E. Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circ. Res. 101 11 (2007) 1155-1163
44. Mayr M., Mayr U., Chung Y.L., Yin X., Griffiths J.R., and Xu Q. Vascular proteomics: linking proteomic and metabolomic changes. Proteomics 4 12 (2004) 3751-3761